86
Views
24
CrossRef citations to date
0
Altmetric
Research Article

Delayed Ocular, Pulmonary, and Cutaneous Complications of Mustards in Patients in the City of Sardasht, Iran

, &
Pages 295-305 | Published online: 02 Dec 2008

References

  • A Forootan. Medical Experiences of Iraq's Chemical Warfare; Tehran, Iran: Taimourzadeh. 2004: 180–188.
  • S Khateri, M Ghanei, MR Souroush, and D Haines. 2003. Effects of mustard gas exposure in pediatric patients. Long-term health status of mustard-exposed children, 14 years after chemical bombardment of Sardasht. J Burn Surg Wound Care [serial online] 2 (1):11. http://www.journalofburns.com. Aug. 2006
  • S Khateri, M Ghanei, and C Palmer. 2002. Long term psycho-social impact of a chemical weapons attack on the population of Sardasht, Iran. ASA Newslett (102):1–5.
  • H Mohammadian. About Sardasht Chemical Warfare Patients; Tehran, Iran: Abed. 2000.
  • S Steward, and D Elder. System of Ophthalmology; St. Louis, MO: Mosby. 1972. 1133–1158.
  • PW Albro, and L Fishbein. 1970. Gas chromatography of sulfur mustard and its analogs. J Chromatogr 46:202–203.
  • CJ West. 1920. The history of mustard gas. Chem Metall Engin 22:541–554.
  • B Papirmeister, A Feister, S Robinson, and R Ford. Medical Defense Against Mustard Gas: Toxic Mechanisms and Pharmacological Implications; Boca Raton, FL: CRC Press. 1991. 91–99.
  • MA Javadi, B Eynollahi, K Jadidi. Determination of the late ocular complications after mustard gas injury. Abstracts of Papers, Seventh Iranian Ophthalmology Conferences, Isfahan, Iran, 1997:43–44.
  • M Ghassemi-Broumand, K Agin, and Z Amiri. 2004. Late ophthalmic and respiratory complications of mustard gas exposure. Bina J Ophthalmol 9 (2):165–171.
  • M Balali. 1984. Clinical and laboratory finding in Iranian fighters with chemical gas poisoning. Arch Beiges (Suppl) 254–255.
  • E Pennisi. 1996. Chemicals behind Gulfwar syndrome. Sci Mag/News/Toxicol 272:479–481.
  • M Ghassemi-Broumand, K Agin, and H Kangari. 2004. The delayed ocular and pulmonary complications of mustard gas. J Cutan Ocul Toxicol 23 (4):293–302.
  • Y Solbery, M Alcalay, and M Belkin. 1991. Ocular injury mustard gas. Surv Ophthalmol 41:461–466.
  • AM Prentiss. Chemicals in War; New York: McGraw-Hill Book Company Inc. 1937. 73–77.
  • IBS Haldane. Callinicus: A Defence of Chemical Warfare; London: Kegan Paul; French: Tribner & Co, 1925. 120–122.
  • MA Javadi. 1997. The ocular complications of mustard gas. Bina J Ophthalmol 3 (1):21–28.
  • D Marzban Rad. Chemical Warfare Agents: Clinical Characteristics and Treatment; Tehran, Iran: Jahad. 1989.
  • M Ghanei, J Aslani, S Khateri, and K Hamadanizade. 2003. Public health status of the civil population of Sardasht 15 years following large-scale wartime exposure to sulfur mustard. J Burn Surg Wound Care [serial online] 2 (1):7. http://www.journalofburns.com. Accessed Dec. 2006
  • JP Robinson. The rise of CB weapons. In: The Problem of Chemical and Biological Warfare; New York: Stockholm International Peace Research Institute. 1971. 137–140.
  • M Etezad-Razavi, M Mahmoudi, M Hefazi, and M Balai. 2006. Delayed ocular complications of mustard gas poisoning and the relationship with respiratory and cutaneous complications. Clin Exp Ophthalmol 34:342–346.
  • United Nations Security Council. Report of the specialists appointed by the Secretary-General to investigate allegations by the Islamic Republic of Iran concerning the use of chemical weapons. United Nations Report S/16433:1984.
  • United Nations Security Council. Report of the mission dispatched by the Secretary-General to investigate allegations of the use of chemical weapons in the conflict between the Islamic Republic of Iran and Iraq. United Nations Report S/18852:1987.
  • J Bournsnel, JA Cohn, M Dixon, GE Francis, GD Greville, DM Needham, and A Wormall. 1946. Studies on mustard gas (BB-dichlorodiethyl sulphide) and some related compounds. The fate of injected mustard gas (containing radioactive sulphur) in the animal body. Biochem J 40:674–756.
  • M Yanoff, and BS Fine. Ocular Pathology. 5th ed; Philadelphia, PA: Mosby. 2002. 301–302.
  • C Timothy, RL Marrs, Maynard, and RS Frederick. Chemical Warfare Agents; Toxicology and Treatment. Canada, Toronto: John Wiley & Sons Ltd. 1996. 101–105.
  • Pharmaceutical Society of Great Britain. Martindale. The Extra Pharmacopoeia, JEF Reynolds, ed. 27th ed; London, UK: The Pharmaceutical Press. 1977:23–27.
  • MC Sulzberger, RL Baer, and A Kanof. 1947. Skin sensitization to vesicant agents of chemical warfare. J Invest Dermatol 8:365–393.
  • B Renshaw. Mechanisms in production of cutaneous injuries by sulfur and nitrogen mustards. In: Chemical Warfare Agents and Related Chemical Problems. vol. 1; Washington, DC: US Office of Scientific Research and Development, National Defense Research Committee. 1946. 479–518.
  • B Papirmeister, CL Gross, JP Petrali, and CJ Hixson. 1984. Pathology produced by sulfur mustard in human skin grafts on athymic nude mice. I. Gross and light microscopic changes. J Toxicol Cutan Ocul Toxicol 3:371–391.
  • B Papirmeister, CL Gross, JP Petrali, and HL Meier. 1984. Pathology produced by sulfur mustard in human skin grafts on athymic nude mice. II. Ultrastructural changes. J Toxicol Cutan Ocul Toxicol 3:393–408.
  • LR Requena, C Requena, M Sanchez, G Jaqueti, A Aguilar, E Sanchez Yuz, and B Hernadwz-Moro. 1988. Chemical warfare, cutaneous lesion from mustard gas. J Am Acad Dermatol 19 (3):529–536.
  • HJ Bruckert, K Schoence, G Schreiber, G Wodtke. The effect of mustard gas on skin: quantitative correlation of exposition, uptake and erythma, Sixth Medical Chemical Defense Bioscience Review, Aug 4–6, 1987:91–98.
  • HP Benschop, GW Moes, A Fidder, AG Scheffer, and GP Schans. 1989. Immunochemical detection of mustard gas adducts with DNA: identification of adducts. Proc Med Def Biosci Rev 132–137.
  • M Nadel. Text Book of Respiratory Medicine. 3rd ed, vol. 1; Philadelphia, PA: WB Saunders. 2000. 201–202.
  • RI Ray, RH Legere, BJ Majerus, and JP Petrali. 1995. Sulfur mustard-induced increase in intracellular free calcium level and arachidonic acid release from cell membrane. Toxicol Appl Pharmacol 131 (L):44–52.
  • I Mann, A Pirie, and BD Pullinger. 1948. An experimental and clinical study of the reaction of the anterior segment of the eye in chcjnical injury, with special reference to cP chemical warfare agents. Br J Ophthalmol XII (Vl):171.
  • JS Friendenwald, RO Scholz, and A Snell. 1948. Studies on the physiology, bio chemistry and cytopathology of the cornea in relation to injury by mustard gas and allied toxic agents. Introduction and outline. Bull Johns Hopkins Hosp 2:81–101.
  • DF Easton, J Peto, and R Doll. 1988. Cancers of the respiratory tract in mustard gas workers. Br J Ind Med 45:652–659.
  • H Akamizu, S Nambu, H Egawa, and M Tokuoka. 1981. Cytological and histological studies on atypical bronchial epithelium in mustard gas ex-workers. Lung Cancer 21:318.
  • H Egawa. 1982. Histological studies on precarcinomatous and early carcinomatous of the tracheobronchial epithelium in mustard gas ex-workers. Hiroshima Med J 30:341–786.
  • H Sohrakptir. Clinical manifestation of chemical agents on Iranian combatants during Iran–Iraq conflict, First World Congress on New Compounds in Biological and Chemical Warfare: Toxicological Evaluation, Ghent, Belgium, 1984:291.
  • J Boark, and FR Sidell. 1992. Agents of chemical warfare: sulfur mustard. Ann Emerg Med 21:303–308.
  • R Salouti. Determination of the late corneal complications in Iranian casualties exposed to mustard gas. Abstracts of Papers, Seventh Iranian Ophthalmology Conferences, Isfahan, Iran, 1997:74.
  • C Rivaud, and T Gerault. 1990. Eye-injuries caused by vesicatory insects. Journal Francaised Ophthalmol 13 (1–2):47–50.
  • S Wada, M Miyanishi, Y Nishimoto, S Kambe, and RW Miller. 1968. Mustard gas as a cause of respiratory neoplasia in man. Lancet i:1161–1163.
  • J Yanagida, S Hozawa, S Ishioka, H Maeda, K Takahashi, T Oyama, M Takaishi, and M Hak. 1988. Somatic mutation in peripheral lymphocytes of former workers at the Okunojima poison gas factory. Jpn J Cancer Res 48:1276–1283.
  • Agency for Toxic Substances and Disease Registry (ATSDR). Toxicological Profile for Mustard Gas; Atlanta, GA: U.S. Department of Health and Human Service, Public Health Service. 1992:101–103.
  • GW Beebe. 1960. Lung cancer in World War I veterans: possible relation to mustard gas injury and 1918 influenza epidemic. J Natl Cancer Inst 5:1231–1251.
  • S Khateri, M Ghanei, S Keshavarz, M Soroush, and D Haines. 2003. Incidence of lung, eye, and skin lesions as late complications in 34000 Iranians with wartime exposure to mustard agent. J Occup Environ Med 45 (11):1136–1143.
  • R Sarah. 1996. Chemical at War. Discover Magazine 17 (Jan):966–972.
  • S Tokuda, Y Hayashi, K Inai, H Egawa, Y Aoki, H Akaiw, R Eto, T Nishida, K One, K Kobukesl Toshfc, S Nambu, T Takemoto, E Kou, H Nlshina, M Fukinfe, S Yonehara, T Tsuga, S Sueniro, and K Horinii. 1986. Early cancer and related lesion in the bronchial epithelium in former workers of mustard gas factory. Acta Pathol Jpn 36:533–542.
  • JH Clavet, A Coste, and M Levame. 1996. Airway epithelial damage induced by sulfur mustard in guinea pigs, effects of glucocorticoids. Hum Exp Toxicol 15:969–971.
  • Z Zhang, BPI Peters, and NA Monterio-Riviere. 1995. Assessment of sulfur mustard interaction with basement membrane. Cell Biol Toxicol 11 (2):89–101.
  • SN Emadi. Prevalence of long term cutaneous effects of mustard gas in 800 Iranian Cw. victims “14–20 years after exposure.” Abstracts of Papers, 7th International Congress of Dermatology, Tehran, Iran, 2004:6.
  • SN Emadi. Determination of the late cutaneous complications of mustard gas in 99 warfare patients, 18 years post injury. Abstracts of Papers, Annual Iranian Dermatology Conferences, Tehran, Iran, 2004:59–60.
  • M Balali. The evaluation of the delayed complications of mustard gas in 1428 warfare patients, during Iran–Iraq war, 1988–1993. Abstracts of Papers, The Annual Iranian Toxicology Conference, 1994;1–2.
  • M Ghassemi-Broumand, GH Karamy, SH Pourfarzam, SN Emadi, and H Ghasemi. 2007. Late concurrent ophthalmic, respiratory, cutaneous and psychiatric complications of chemical weapons exposure in 476 war patients. Daneshvar Med 70 (4):81–92.
  • M Ghassemi-Broumand. The evaluation of the ocular complications in 1000 warfare patients, five years post injury with chemical gases. Abstracts of Papers, The Annual Iranian Ophthalmology Conferences, Tehran, Iran, 1994:82–85.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.